前列腺癌患者筛状组织学模式的肿瘤学结局:系统评价与荟萃分析
该系统评价与荟萃分析纳入31项研究,评估根治性前列腺切除标本中筛状模式与不良病理及肿瘤学结局的关联。结果显示筛状模式与前列腺外侵犯、精囊侵犯、切缘阳性、生化复发及癌症特异性死亡风险升高相关。作者认为应更规范地报告筛状模式以指导严格随访。
要点
- 筛状模式与前列腺外侵犯风险升高相关(OR 1.96,P < 0.0001)。
- 筛状模式与精囊侵犯(OR 2.89,P < 0.01)和切缘阳性(OR 1.88,P < 0.0007)相关。
- 筛状模式与生化复发(HR 2.14,P < 0.01)和癌症特异性死亡(HR 3.30,P < 0.01)风险升高相关。
核心结论
- 筛状模式的存在与根治性前列腺切除术后不良病理、更差的生化复发及癌症特异性死亡相关。
- 作者认为这些结果凸显了更规范地病理报告筛状模式的重要性,以便建议临床医生对前列腺癌患者进行严格随访。
研究设计与样本
- 系统评价与荟萃分析,已在PROSPERO注册(CRD42022298473)。
- 检索PubMed、EMBASE和Scopus至2021年12月,并检索相关文献的参考文献列表。
- 纳入提供根治性前列腺切除标本筛状模式与前列腺外侵犯、精囊侵犯、切缘阳性、生化复发或癌症特异性死亡关联定量数据的已发表期刊文章。
- 共纳入31项研究进行定量分析,文章发表于2011年至2022年共11年间,平均随访62.87个月。
- 研究平均质量经纽卡斯尔-渥太华量表评估为6.27。
主要发现
- 筛状模式与前列腺外侵犯风险升高相关(OR 1.96;P < 0.0001)。
- 筛状模式与精囊侵犯风险升高相关(OR 2.89;P < 0.01)。
- 筛状模式与切缘阳性风险升高相关(OR 1.88;P < 0.0007)。
- 筛状模式与生化复发风险升高相关(HR 2.14;P < 0.01)。
- 筛状模式与癌症特异性死亡风险升高相关(HR 3.30;P < 0.01)。
临床怎么用
- 作者认为应更规范地病理报告筛状模式,以便建议临床医生对前列腺癌患者进行严格随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Changes applied to the Prostate cancer (PCa) histopathology grading, where patients with cribriform patterns (CP) may be categorized as grade group 2 and could hypothetically be surveilled. However, CP has been associated with worse oncological outcomes. The aim of our study is to systematically review and meta-analyze the available evidence on CP in PCa patients. METHODS: This analysis was registered on PROSPERO (CRD42022298473). We performed a systematic literature search of PubMed, EMBASE and Scopus using Medical Subject Headings (MeSH) indexes, keyword searches, and publication types until December 2021. The search terms included: "prostate", "prostate cancer" and "cribriform". We also searched reference lists of relevant articles. Eligible studies included published journal articles that provided quantitative data on the association between cribriform patterns at radical prostatectomy and the presence of extra-prostatic extension (EPE), seminal vesicle invasion (SVI), positive surgical margins (PSM), biochemical recurrence (BCR) or cancer specific mortality (CSM). RESULTS: Overall, 31 studies were included for the quantitative analysis. All articles have been published during a span of 11 years (2011-2022) with a mean month of follow-up of 62.87 months. The mean quality of these studies, assessed with the Newcastle Ottawa Scale was 6.27. We demonstrated that CP was associated with greater risk of EPE (odds ratio [OR] 1.96; P < 0.0001), SVI (OR: 2.89; p < 0.01), and PSM (OR: 1.88; p < 0.0007). Our analyses showed that CP was associated with greater risk of BCR (hazard ratio [HR]: 2.14; p < 0.01) and of CSM (HR: 3.30, p < 0.01). CONCLUSION: The presence of CP is associated with adverse pathology at radical prostatectomy and worse biochemical recurrence and cancer specific mortality. These results highlight the importance of a better pathologic report of CP to advise clinician for a strict follow-up in PCa patients.
引用
- Russo GI, Soeterik T, Puche-Sanz I, et al. Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2022. PMID: 36216967. doi:10.1038/s41391-022-00600-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。